47.38USD+1.07%Mkt Cap: 18.69B USDP/E: —Last update: 2026-05-26
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal in…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap18.69B USD
Enterprise Value14.85B USD
Revenue (TTM)2.22B USD
Gross Profit1.05B USD
Net Income (TTM)-2.82B USD
Revenue/Share5.687 USD
Last Price47.38 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS60770K1079
Valuation
P/E (Trailing)—
P/E (Forward)-11.24
PEG—
EV/EBITDA-6.46
EV/Revenue6.67
P/S8.43
P/B2.15
EPS (TTM)-8.14
EPS (Forward)-4.20
52W Range
22.2867% of range59.55
52W High59.55 USD
52W Low22.28 USD
Profitability
Gross Margin54.84%
Oper. Margin-131.10%
EBITDA Margin-103.33%
Profit Margin-146.83%
ROE-32.62%
ROA-22.87%
Growth
Revenue Growth260.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.87B USD
CapEx (TTM)202.00M USD
FCF Margin-0.90%
FCF Yield-0.11%
Net Debt-3.91B USD
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.15
Current Ratio2.41
Quick Ratio2.23
Book Value/Sh21.95 USD
Cash/Share13.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)43.20 USD
Target Range21.00 USD – 69.00 USD
# Analysts20
Ownership
Shares Out.396.79M
Float370.10M
Insiders7.30%
Institutions78.92%
Short Interest
Short Ratio10.3d
Short % Float17.98%
Short % Out.14.70%
Shares Short58.31M
Short (prev mo.)60.65M
Technical
SMA 5050.75 (-6.6%)
SMA 20036.95 (+28.2%)
Beta1.06
S&P 52W Chg28.31%
Avg Vol (30d)7.22M
Avg Vol (10d)10.00M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—